DRIFT fluctuated 52.4% in 24 hours: Tether's support of a $127.5 million recovery plan triggered a pump followed by a pullback
Bitget Pulse2026/04/17 00:59Brief Overview of Volatility
In the past 24 hours, DRIFT's price surged from a low of $0.0412 to a high of $0.0628, currently trading at $0.0488, with a price fluctuation amplitude of 52.4%. The 24-hour trading volume is approximately $36.25 million; CEX saw a net outflow of about $175,000, DEX had a net outflow of around $10,000, leading to a total capital net outflow of $236,000.
Analysis of Reasons for Abnormal Price Movements
- Tether led the recovery fund of $127.5 million to $150 million to compensate users and restart the platform, replacing USDC with USDT. This announcement directly fueled an intraday pump of over 20%-30% in price.
- The subsequent pullback may be due to profit-taking, combined with the recent $280 million hack incident background.
Market Views and Outlook
Market sentiment has turned optimistic, with the X community actively discussing the Tether partnership pushing $DRIFT to intraday highs. However, mainstream opinion remains cautious: the price is still more than 70% below pre-hack levels, so the short-term rebound may be limited, and attention should be paid to execution of recovery and the risks associated with USDC replacement.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hundred Billion ARR and 18.4 Billion Burn Rate: SpaceX (SPCX.US) First Quarterly Report Faces Off Between "Growth and Cost"
After the U.S. stock market closed on August 4, SpaceX released its first quarterly report since going public. Despite second-quarter revenue doubling significantly and management providing strong guidance to reach $100 billion ARR by the end of the year, the company's stock price plunged by more than 9% after hours.
Dogecoin: Is DOGE’s record-low RSI a buy signal or bull trap?
Novo Nordisk (NVO.US) Q2 results beat expectations and full-year guidance is raised, but concerns remain! Wegovy oral drug sales are weak, and the path to renewed growth is still uncertain
Although Novo Nordisk reported better-than-expected Q2 2026 results and raised its full-year guidance, it did not address the issue that is of most concern to Wall Street.
Biconomy Price Prediction: BICO Surges 126% Weekly as Bulls Target $0.03
Crypto prices
More
